Why the study?
Does the AMPK inhibitor compound C abrogate the protective effects of ischemic postconditioning in rat hearts?
Does the AMPK inhibitor compound C abrogate the protective effects of ischemic postconditioning in rat hearts?
AMPK appears to play a role in ischemic postconditioning but is not the major cellular mediator for preserving cell viability in rat hearts.
AMPK mediates select postconditioning effects in rat hearts; leaves open primary mediators of cell viability.
Ischemic postconditioning (IPOC) protects the myocardium from ischemic-reperfusion injury, improving functional recovery and cell viability. This protection is concurrent with stimulation of glycogen breakdown, increased mitochondrial ATP synthesis and content, maintenance of reduced-to-oxidized glutathione ratio (GSH/GSSG), and decreased oxidative damage. The present study's objective was to assess whether these effects are associated with increased resistance to mitochondrial permeability transition pore (MPTP) opening. The effects of the AMP-activated protein kinase (AMPK) inhibitor, compound C (CC), were measured to investigate association with AMPK. Mitochondria removed from postconditioned hearts required higher calcium levels to induce MPTP opening. Improved functional recovery, increased glycogen mobilization, maintenance of the GSH/GSSG ratio, decreased oxidative damage, and increased resistance to MPTP opening were abrogated when the hearts were postconditioned in the presence of CC, without affecting preservation of cell viability. Although AMPK appears to play a role in IPOC, it would not be the major cellular mediator.
No takes yet. Share an insight, caveat, or question.
Hermann et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: